Login / Signup

Choice of time horizon critical in estimating costs and effects of changes to HIV programmes.

Nicky McCreeshIoannis AndrianakisRebecca N NsubugaMark StrongIan VernonTrevelyan J McKinleyJeremy E OakleyMichael GoldsteinRichard HayesRichard G White
Published in: PloS one (2018)
Model results suggest that the change in threshold is unlikely to have been cost-effective to date, but is likely to be highly cost-effective in Uganda by 2030. The time horizon needs to be chosen carefully when projecting intervention effects. Large amounts of uncertainty in our results demonstrates the need to comprehensively incorporate uncertainties in model parameterisation.
Keyphrases
  • randomized controlled trial
  • antiretroviral therapy
  • hiv infected
  • human immunodeficiency virus
  • hiv positive
  • hepatitis c virus
  • hiv aids
  • hiv testing
  • south africa